Skip to main content
. 2018 Apr 12;23(8):891–899. doi: 10.1634/theoncologist.2017-0582

Figure 2.

image

Dermatologic adverse events in patients treated with osimertinib. (A): Face acneiform rash. (B): Pruritus on back. (C): Xerotic dermatitis on legs. (D): Paronychia of the great toe and dry skin (left) and paronychia of the fingers (right). (E): Brittle nails of the fingers.